Greece Cannabis Regulations — Medical, Cultivation, and Retail Laws

Executive Summary

Greece is tightening its cannabis regulations in May 2026 by banning sales at kiosks and mini markets, marking a significant policy shift in one of Europe's emerging cannabis markets. The Greek government's decision to restrict retail channels comes approximately three years after the country liberalized certain cannabis products for consumer purchase. This regulatory tightening affects the distribution network for low-THC cannabis products that had become available through convenience retail outlets across the country. The move reflects ongoing tensions between market liberalization and regulatory control as European nations navigate cannabis policy reform. Greece's medical cannabis program, established in 2017, remains separate from these retail restrictions and continues to operate under pharmaceutical distribution channels. The policy change impacts retailers, consumers, and the nascent Greek cannabis industry, which had attracted international investment following earlier liberalization measures.

Why This Matters

Greece's regulatory reversal affects approximately 15,000 kiosks and mini markets that had begun selling cannabis products, along with millions of Greek consumers and international cannabis companies operating in the Mediterranean market. The Greek cannabis market represents a critical test case for European cannabis policy. With a population of 10.7 million and a strategic position in southeastern Europe, Greece's regulatory approach influences neighboring Balkan nations and serves as a bellwether for EU cannabis policy evolution. The kiosk and mini market channel had become a significant distribution network, with industry estimates suggesting these outlets generated €40-60 million in annual cannabis product sales since liberalization. International cannabis companies including Canadian licensed producers and European pharmaceutical firms had invested in Greek cultivation and distribution infrastructure, viewing the country as a gateway to broader European markets. The regulatory tightening creates uncertainty for these operators and may impact the estimated €200 million in foreign direct investment that flowed into Greek cannabis operations between 2020 and 2025. For Greek consumers, the policy change restricts access to legal cannabis products that had become normalized through convenience retail. Public health advocates and law enforcement had raised concerns about youth access through these unregulated channels, while industry participants argued that kiosks provided controlled access points with age verification requirements.

Background and History

Greece's cannabis policy has evolved dramatically over the past decade, from strict prohibition to medical legalization to retail experimentation and now regulatory contraction.

Early Prohibition Era (Pre-2017)

Greece maintained strict cannabis prohibition throughout the 20th century, with possession and cultivation criminalized under Law 3459/2006. Personal use possession carried penalties including fines and potential imprisonment, though enforcement varied significantly across regions. The country's conservative approach reflected broader Mediterranean attitudes toward drug policy, with Greece serving as a transit point for cannabis entering Europe from North Africa and the Middle East.

Medical Cannabis Legalization (2017)

In July 2017, the Greek Parliament passed Law 4523/2018, establishing a legal framework for medical cannabis cultivation, production, and distribution. The legislation permitted licensed companies to cultivate cannabis for pharmaceutical purposes and allowed physicians to prescribe cannabis-based medicines for specific conditions including chronic pain, multiple sclerosis, and chemotherapy side effects. The Ministry of Rural Development and Food assumed regulatory authority over cultivation licensing, while the National Organization for Medicines regulated pharmaceutical products. The 2017 framework attracted immediate international interest, with Canadian companies Aurora Cannabis and Aphria (later Tilray) announcing Greek investments in 2018. Domestic pharmaceutical companies including Viohalco subsidiary Biopharm also entered the sector. By 2020, Greece had issued approximately 15 cultivation licenses covering over 200 hectares of production capacity.

Hemp and Low-THC Product Liberalization (2023)

In March 2023, Greece implemented EU-aligned regulations permitting the sale of hemp-derived products containing less than 0.2% THC. This regulatory change, enacted through ministerial decree rather than parliamentary legislation, allowed retailers including kiosks and mini markets to sell CBD products, hemp flowers, and related items without specialized licensing beyond standard retail permits. The 2023 liberalization created a rapid expansion of retail availability. Kiosks, which function as ubiquitous convenience outlets in Greek cities and towns, began stocking hemp flowers, CBD oils, and pre-rolled hemp cigarettes. Industry associations estimated that within 18 months, over 8,000 kiosks had added cannabis products to their inventory alongside traditional tobacco, beverages, and snacks.

Regulatory Concerns Emerge (2024-2025)

By late 2024, concerns about the kiosk distribution model began surfacing. The Hellenic Police reported increased complaints about youth access, with enforcement officers documenting sales to minors at approximately 15% of inspected outlets. Public health organizations including the Greek Association of Pediatrics raised concerns about normalization of cannabis use among adolescents. Simultaneously, quality control issues emerged. The General Chemical State Laboratory documented cases of mislabeled products, with some hemp flowers testing above the 0.2% THC threshold. The lack of specialized retail requirements meant kiosk operators received no training in product handling, storage, or age verification specific to cannabis products. The Ministry of Health commissioned a review of the retail framework in January 2025, examining implementation challenges and public health impacts. That review, completed in March 2025, recommended restricting sales to specialized licensed retailers with enhanced compliance requirements.

Policy Reversal Announced (May 2026)

On May 17, 2026, the Greek government announced plans to ban cannabis product sales at kiosks and mini markets, according to reporting by To Vima. The policy change, expected to take effect within 90 days of formal publication, will restrict legal cannabis sales to licensed specialty retailers meeting enhanced regulatory standards including staff training, product storage requirements, and enhanced age verification systems.

Key Players

Ministry of Health

The Ministry of Health holds primary regulatory authority over cannabis policy implementation in Greece. Under Minister Adonis Georgiadis, the ministry has emphasized public health protection and youth access prevention as policy priorities. The ministry commissioned the 2025 retail framework review and developed the kiosk ban proposal. Ministry officials have stated that specialized retail channels provide better regulatory oversight and consumer protection compared to general convenience outlets.

Ministry of Rural Development and Food

This ministry oversees cultivation licensing for medical cannabis production under the 2017 framework. The ministry has issued licenses to domestic and international operators and maintains oversight of agricultural compliance including THC testing and security requirements. The retail channel restrictions do not directly impact cultivation licensing, though reduced retail access may affect demand for legally produced hemp flowers.

Hellenic Police

Law enforcement agencies have supported retail restrictions, citing enforcement challenges with the dispersed kiosk network. Police unions have argued that concentrating sales in licensed specialty retailers improves compliance monitoring and reduces youth access. The Hellenic Police documented approximately 450 violations of age restriction requirements at kiosks during 2024-2025 enforcement sweeps.

Pan-Hellenic Association of Kiosk Owners

This trade association represents approximately 12,000 kiosk operators nationwide and has opposed the retail ban. The association argues that kiosks provide controlled access with existing age verification systems used for tobacco and alcohol sales. Association representatives estimate that cannabis products generated €3,000-5,000 in monthly revenue per outlet, representing a significant income stream for small business operators. The association has threatened legal challenges to the ban on grounds of disproportionate economic impact.

Greek Cannabis Industry Association

This industry group represents licensed cultivators, processors, and distributors. The association has expressed mixed reactions to the retail restrictions, with some members supporting specialized retail channels as enhancing product quality and brand differentiation, while others worry about reduced market access. The association has advocated for a licensing framework that permits existing retailers to obtain specialized cannabis retail permits rather than complete prohibition.

International Cannabis Operators

Companies including Tilray, which operates Greek cultivation facilities through its Aphria acquisition, have significant exposure to Greek regulatory changes. These operators primarily focus on medical cannabis and export markets, but retail channel restrictions may impact domestic demand for hemp products. Several Canadian and Israeli companies had announced plans for Greek retail operations that may now require restructuring.

Legal and Regulatory Framework

Greece's cannabis legal structure operates through multiple legislative instruments spanning medical authorization, agricultural regulation, and retail commerce.

Primary Legislation

Law 4523/2018 established the medical cannabis framework, amending earlier pharmaceutical regulations to permit cannabis-based medicines. The statute authorizes the Ministry of Rural Development and Food to license cultivation facilities meeting security, testing, and quality standards. Licensed cultivators may produce cannabis containing THC levels appropriate for pharmaceutical use, with no upper limit specified in the statute itself. Law 3459/2006 continues to criminalize unauthorized cannabis possession, cultivation, and distribution. Personal possession of small quantities may result in administrative fines rather than criminal prosecution under prosecutorial discretion guidelines, though no formal decriminalization statute exists. The law distinguishes between personal use quantities and amounts suggesting commercial intent, with the latter carrying mandatory minimum sentences.

Hemp Regulations

Greece implemented EU Regulation 1307/2013, which permits hemp cultivation for industrial purposes when THC content remains below 0.2%. The 2023 ministerial decree extended this framework to retail sales of hemp-derived products, aligning Greek policy with broader European hemp commerce. The decree did not establish specialized retail licensing requirements, instead permitting sales through existing commercial channels subject to general retail regulations.

Retail Commerce Framework

The forthcoming kiosk ban will operate through amendment to the 2023 ministerial decree. The government has indicated that new regulations will establish a specialized cannabis retail license requiring applicants to demonstrate compliance with enhanced standards including staff training certification, secure product storage, electronic age verification systems, and regular compliance auditing. Existing specialty tobacco shops and pharmacies are expected to be eligible for these licenses, while general convenience retailers will be excluded. The regulatory framework does not currently specify possession limits for legal hemp products, though the 0.2% THC threshold effectively limits psychoactive potential. Medical cannabis patients may possess quantities specified in their physician prescriptions, typically 30-day supplies.

Enforcement Mechanisms

The General Chemical State Laboratory conducts product testing to verify THC content and labeling accuracy. Violations may result in product seizure, administrative fines ranging from €5,000 to €50,000, and potential criminal charges for products exceeding legal THC thresholds. The Hellenic Police conduct retail compliance inspections, with violations of age restriction requirements carrying fines of €1,000-10,000 per incident.

Market and Business Implications

The retail restrictions will reshape Greece's cannabis market structure, concentrating sales in specialized channels and potentially reducing overall market access and revenue.

Retail Channel Disruption

The kiosk and mini market channel represented an estimated 60-70% of legal cannabis product retail volume in Greece. Industry analysts project that the ban will reduce retail points of sale from approximately 15,000 outlets to an estimated 500-800 licensed specialty retailers within the first year of implementation. This concentration may improve per-store economics for remaining retailers but will significantly reduce geographic access, particularly in rural areas where kiosks often serve as the only local retail option. Kiosk operators face immediate inventory losses, with unsold cannabis products becoming unsaleable after the ban takes effect. Industry estimates suggest €15-20 million in stranded inventory across the kiosk network, with no government compensation program announced. Some kiosk associations have proposed a buyback program to mitigate operator losses.

Licensed Cultivator Impact

Greek-licensed hemp cultivators had expanded production to serve the retail market, with approximately 500 hectares dedicated to hemp flower production for domestic consumption. The retail channel reduction may create oversupply conditions, depressing wholesale prices and potentially forcing some cultivators to exit the market or pivot to export-focused production. Medical cannabis cultivators operating under pharmaceutical licenses face less direct impact, as their products distribute through pharmacy channels unaffected by the kiosk ban. However, reduced normalization of cannabis through retail presence may impact medical program enrollment and physician willingness to prescribe cannabis-based medicines.

International Investment Implications

Greece had positioned itself as an attractive European cannabis investment destination, offering lower production costs than northern European markets and year-round cultivation potential. The regulatory reversal may deter future investment by signaling policy instability. Several announced retail ventures by international operators have been placed on hold pending clarity on the new licensing framework. Conversely, some institutional investors view the move toward specialized retail as market maturation that may improve long-term sustainability by reducing regulatory risk and enhancing product quality standards. The transition may favor well-capitalized operators capable of securing specialized retail licenses over smaller entrepreneurs.

Pricing and Access Dynamics

Reduced retail competition may increase consumer prices as specialized retailers face higher compliance costs and reduced competitive pressure. Industry analysts project retail price increases of 15-25% for hemp products following the transition to specialized channels. Higher prices may drive some consumers toward illicit market alternatives, potentially undermining the policy goal of channeling demand into regulated commerce. Geographic access will decline significantly, particularly affecting rural and island communities. The requirement for specialized retail infrastructure may delay license issuance in smaller markets, creating temporary access deserts during the transition period.

What Experts Say

Public health researchers, industry representatives, and policy analysts offer divergent perspectives on Greece's regulatory tightening. Dr. Konstantinos Farsalinos, a public health researcher at the University of Patras, has argued that specialized retail channels provide better age verification and product quality control compared to general convenience outlets. According to his research on tobacco retail, specialized shops demonstrate higher compliance rates with age restriction requirements and provide more informed consumer guidance. He has stated that the kiosk model prioritized market access over public health protection. The European Industrial Hemp Association has expressed concern that retail restrictions may undermine the legal hemp industry across Europe by creating precedent for other nations to reverse liberalization measures. The association's position emphasizes that hemp products with 0.2% THC pose minimal public health risk and that retail restrictions represent disproportionate regulatory response to implementation challenges that could be addressed through enhanced compliance monitoring. Greek economists have noted that the policy change reflects broader tensions in cannabis policy between economic liberalization and social control. Professor Maria Karamessini of Panteion University has analyzed the kiosk ban as representing a reassertion of state regulatory authority following a period of rapid market-driven expansion that outpaced institutional capacity for oversight. Industry consultants specializing in European cannabis markets have observed that Greece's experience mirrors challenges in other jurisdictions that implemented rapid liberalization without adequate retail frameworks. They note that successful cannabis retail models typically involve graduated licensing systems with clear compliance requirements from the outset, rather than open access followed by restriction. Patient advocacy organizations have emphasized that medical cannabis access through pharmacy channels must be protected and expanded regardless of retail market restrictions. These groups argue that conflating hemp retail with medical access risks undermining physician confidence in cannabis-based medicines and patient willingness to pursue legal medical options.

What's Next

Implementation of the kiosk ban will unfold over the next 6-12 months, with significant regulatory and market developments expected. The Greek government is expected to publish formal regulations establishing the specialized cannabis retail licensing framework by July 2026. The regulations will specify application requirements, compliance standards, and fee structures. Industry observers anticipate application fees of €2,000-5,000 with annual renewal fees of similar magnitude, creating barriers to entry for smaller operators. A 90-day transition period following regulatory publication will allow existing kiosk and mini market operators to sell remaining inventory. During this period, the Ministry of Health will begin accepting applications for specialized retail licenses. Initial license issuance is expected to begin in October 2026, with the first licensed specialty retailers opening in November-December 2026. Legal challenges to the ban are anticipated from kiosk operator associations, potentially delaying implementation. Greek administrative courts have authority to issue preliminary injunctions suspending regulatory changes pending judicial review. Any legal challenge would likely focus on proportionality arguments and economic impact on small business operators. The European Commission may review Greece's retail restrictions for compatibility with EU single market principles, particularly regarding hemp products legal under EU agricultural regulations. However, member states retain significant discretion over retail commerce regulation, and the Commission is unlikely to challenge restrictions based on public health rationales. International cannabis companies will reassess Greek market strategies during the transition period. Some operators may pursue specialized retail licenses, while others may refocus on export-oriented production or exit the Greek market entirely. Consolidation among Greek cannabis operators is likely as the market adjusts to reduced retail access. Public health researchers will monitor youth access and consumption patterns following implementation. If specialized retail channels demonstrate improved compliance and reduced youth access, the Greek model may influence policy in other European nations considering cannabis retail frameworks. Conversely, if illicit market activity increases, the policy may be viewed as counterproductive. The Greek Parliament may consider broader cannabis policy reform in 2027-2028, potentially including adult-use legalization or expanded medical access. However, the current government has indicated no plans for further liberalization, instead emphasizing the need to consolidate existing regulatory frameworks before considering additional policy changes.

Further Reading

• Law 4523/2018 (Greek Medical Cannabis Framework) - Official Government Gazette: https://www.et.gr/api/DownloadFeksApi/?fek_pdf=20180100138
• EU Regulation 1307/2013 (Common Agricultural Policy, Hemp Provisions) - EUR-Lex: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32013R1307
• Greek Ministry of Health Cannabis Policy Page: https://www.moh.gov.gr
• European Monitoring Centre for Drugs and Drug Addiction - Greece Country Profile: https://www.emcdda.europa.eu/countries/greece_en
• Hellenic Police Drug Enforcement Statistics (Annual Report 2025): https://www.hellenicpolice.gr
• To Vima Original Reporting on Kiosk Ban (May 17, 2026): https://www.tovima.gr
• European Industrial Hemp Association Position Papers: https://eiha.org
• General Chemical State Laboratory Testing Protocols: https://www.gcsl.gr